Unemployment rate drops in Tri-Counties, still in double digits
Unemployment rates in Ventura, Santa Barbara and San Luis Obispo counties continued to inch downward in July, though all three remained at historically high levels in the fourth month of the coronavirus pandemic. The combined civilian unemployment rate for the tri-county area was 10.7 percent in July, according to a Business Times analysis of data Read More →
PennyMac’s quarter to remember
With mortgage rates at record lows and the homebuying and refinancing markets booming, PennyMac Financial Services, a Westlake Village mortgage lender, and its real estate investment trust both reported strong financial results on Aug. 6. PennyMac Financial Services announced a net income of $352.7 million for the second quarter of 2020, or $4.39 per share, Read More →
Amgen teams up with competitors in COVID treatment trial
Amgen has joined two of its competitors in launching a trial for drugs to treat patients with COVID-19. Together with Chicago-based AbbVie and Japanese drugmaker Takeda Pharmaceutical, the Thousand Oaks biotech giant said Aug. 3 it had enrolled the first patients into a clinical trial for the anti-inflammatory drugs Otezla, cenicriviroc and Firazyr. Otezla is Read More →
LTC sees big revenue drop after rent losses
LTC Properties’ net income dropped more than 90 percent from the second quarter of 2019 to the second quarter of 2020, as the Westlake Village-based senior-housing property investment trust wrote off $17.7 million in rent. LTC’s stock dropped after the July 31 earnings announcement. It opened at $38.38 on Aug. 1 and was at $36.78 Read More →
Saalex, AeroVironment help NASA get to Mars with morning Perseverance launch
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen meets analyst estimates, but shares drop on Q2 earnings decline
Amgen’s revenues climbed 6 percent in the second quarter, to $6.2 billion, despite the COVID-19 pandemic limiting hospital and physician operations and putting a hitch in diagnosis and treatment for many patients. Amgen’s earnings, announced July 28, met average analyst estimates. However, a 17 percent overall decline in net income for the Thousand Oaks biotech Read More →
Teledyne stock climbs as Q2 earnings beat analyst estimates
Second-quarter sales for Thousand Oaks-based Teledyne Technologies dipped 5 percent to $743.3 million, and net income beat analyst estimates, sending the stock up 2.5 percent in early trading. Net income fell around 10 percent compared to the previous year’s second quarter to $93.7 million, or $2.48 per share, squarely beating analyst predictions of around $2 Read More →
